Smart Inhalers
North America · 1 shared keyword
Updated
Reviewed by Vidhi Upadhyay
North America Home Oxygen Therapy Market Industry Trends and Forecast to 2034: Segmented by (Product, Indication, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$1.32 Bn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $1.85 Bn | — | — |
| 2025 (base) | $1.95 Bn | +$108.9 Mn | — |
| 2026 (forecast) | $2.07 Bn | +$115.3 Mn | +5.9% |
| 2027 (forecast) | $2.19 Bn | +$122.1 Mn | +12.1% |
| 2028 (forecast) | $2.32 Bn | +$129.3 Mn | +18.8% |
| 2029 (forecast) | $2.46 Bn | +$136.9 Mn | +25.8% |
| 2030 (forecast) | $2.60 Bn | +$145.0 Mn | +33.2% |
| 2031 (forecast) | $2.76 Bn | +$153.5 Mn | +41.1% |
| 2032 (forecast) | $2.92 Bn | +$162.6 Mn | +49.4% |
| 2033 (forecast) | $3.09 Bn | +$172.2 Mn | +58.2% |
| 2034 (forecast) | $3.27 Bn | +$182.4 Mn | +67.5% |
Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
| Market size, 2025 | $1.95 Bn placeholder estimate |
|---|---|
| Forecast, 2034 | $3.27 Bn placeholder estimate |
| Growth (CAGR), 2025–2034 | 5.9% placeholder estimate |
| Years | 2024 historical · 2025 base year · 2026–2034 forecast |
| Segments | Product, indication and end user (see all) |
| Key players | Inogen, Philips Healthcare, ResMed Inc., Linde, Air Liquide (see all) |
| Formats | PDF, PPTX, XLSX |
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
Home oxygen therapy supplies extra oxygen at home or on the go for people with long-term lung disease.
Key segments of the home Oxygen Therapy market include product (Oxygen Concentrators, Portable Concentrators and Oxygen Cylinders) and indication (COPD, Pulmonary Fibrosis and Heart Failure).
Rising rates of chronic disease linked to diabetes, ageing, smoking and pollution, plus new treatments that slow disease, are driving the home Oxygen Therapy market.
Earlier screening, new drug classes and home-based care give the home Oxygen Therapy market room to grow.
Late diagnosis, high prices of new medicines, limited specialist care and poor adherence hold back the home Oxygen Therapy market.
The home Oxygen Therapy market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
In the countries we cover here, medical devices are regulated by Health Canada (Canada)[1] and FDA (US)[2]. How care is paid for in these countries: provincial health insurance (Canada)[3] and Medicare and Medicaid (US)[4].
[1] Health Canada. Checked 14 Nov 2026.
[2] US Food and Drug Administration. Checked 14 Nov 2026.
[3] Health Canada. Checked 14 Nov 2026.
[4] Centers for Medicare & Medicaid Services. Checked 14 Nov 2026.
Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how home Oxygen Therapy products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in North America.
What doctors and scientists are doing in Home Oxygen Therapy right now, from free public sources.
Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
From our blog
North America · 1 shared keyword
North America · 1 shared keyword
North America
North America
North America
North America
Healthcare Services · North America
Digital Health · North America
Pharmaceuticals · North America
Digital Health · North America
Pharmaceuticals · North America
Pharmaceuticals · North America